SLC1A2 and amyotrophic lateral sclerosis: Pointedly, transgenic murine ALS models and human post-mortem tissue have shown decreased excitatory amino acid transporter 2 (EAAT2; mouse analog GLT1), which clears synaptic glutamate [7], [8], [9].